Windlas Biotech Ltd (WINDLAS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003519, "name": "Windlas Biotech", "stock_name": "Windlas Biotech", "full_name": "Windlas Biotech Ltd", "name_url": "stocks-analysis/windlas-biotech", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "722.65", "chg": 4.3, "chgp": "0.6%", "dir": 1, "prev_price": "718.35", "mcapval": "1,525.24 Cr", "mcap": "Small Cap", "scripcode": 543329, "symbol": "WINDLAS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0H5O01029", "curr_date": "Mar 20", "curr_time": "", "bse_nse_vol": "13.0 k", "exc_status": "Active", "traded_date": "Mar 20, 2026", "traded_date_str": "2026 03 20", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/windlas-biotech-1003519-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Windlas Biotech Ltd Falls to 52-Week Low Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-falls-to-52-week-low-amidst-continued-downtrend-3893795", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_priceRelatedfactors_3893795.png", "date": "2026-03-16 11:49:40", "description": "Windlas Biotech Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.699.35, marking a significant decline amid broader market pressures and company-specific performance factors." }, { "title": "Windlas Biotech Valuation Shifts to Fair Amidst Sector Comparisons", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-valuation-shifts-to-fair-amidst-sector-comparisons-3892675", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_valuationdot_3892675.png", "date": "2026-03-16 08:01:24", "description": "Windlas Biotech Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating as of early February 2026. This change reflects evolving market perceptions amid a competitive pharmaceutical and biotechnology sector, with key valuation multiples such as price-to-earnings (P/E) and price-to-book value (P/BV) adjusting relative to historical averages and peer benchmarks." }, { "title": "Windlas Biotech Declines 2.24% Amid Valuation Shift and Bearish Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-declines-224-amid-valuation-shift-and-bearish-momentum-3890591", "imagepath": "", "date": "2026-03-14 10:06:31", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>09 Mar:</strong> Stock hits 52-week low at Rs.708.90 amid market downturn</p>\n <p><strong>09 Mar:</strong> Technical downgrade to Sell rating confirmed bearish momentum</p>\n <p><strong>09 Mar:</strong> Valuation shifts to attractive rating despite price weakness</p>\n <p><strong>13 Mar:</strong> Week closes at Rs.726.75, down 2.24%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.743.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-val..." }, { "title": "Windlas Biotech Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/windlas-biotech-ltd-is-rated-sell-3882611", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_mojoScore_3882611.png", "date": "2026-03-10 10:10:18", "description": "Windlas Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Windlas Biotech Ltd Stock Falls to 52-Week Low Amidst Market Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-stock-falls-to-52-week-low-amidst-market-downturn-3880306", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_priceRelatedfactors_3880306.png", "date": "2026-03-09 13:56:49", "description": "Windlas Biotech Ltd’s shares declined sharply to a new 52-week low of Rs.708.9 on 9 Mar 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and the broader market over the past year, reflecting subdued financial results and valuation pressures." }, { "title": "Windlas Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-faces-bearish-momentum-amid-technical-downgrade-3879097", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_technicaldot_3879097.png", "date": "2026-03-09 08:01:59", "description": "Windlas Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests increasing downside pressure amid a challenging market environment for the Pharmaceuticals & Biotechnology sector." }, { "title": "Windlas Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-valuation-shifts-signal-renewed-price-attractiveness-3878887", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_valuationdot_3878887.png", "date": "2026-03-09 08:00:52", "description": "Windlas Biotech Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a downgrade in its overall Mojo Grade to Sell. This change reflects evolving market perceptions amid a challenging pharmaceutical sector landscape, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now presenting a more compelling entry point relative to peers and historical averages." }, { "title": "Windlas Biotech Declines 1.70% Amid Mixed Technical Signals and Sector Headwinds", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-declines-170-amid-mixed-technical-signals-and-sector-headwinds-3878116", "imagepath": "", "date": "2026-03-07 12:02:19", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Stock opens at Rs.754.45 amid broad market decline</p>\n <p><strong>4 Mar:</strong> Windlas Biotech hits 52-week low of Rs.728.15</p>\n <p><strong>5 Mar:</strong> Bearish momentum intensifies with technical indicators shifting</p>\n <p><strong>6 Mar:</strong> Technical momentum shifts to mildly bearish amid mixed signals</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.756.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-..." }, { "title": "Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/windlas-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-3875246", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/WindlasBiotechL_technicaldot_3875246.png", "date": "2026-03-06 08:02:52", "description": "Windlas Biotech Ltd has experienced a subtle but noteworthy shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid broader market volatility." } ], "total": 274, "sid": "1003519", "stock_news_url": "https://www.marketsmojo.com/news/windlas-biotech-1003519" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Windlas Biotech Ltd has declared <strong>116%</strong> dividend, ex-date: 21 Jul 25", "dt": "2025-07-21", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

09 Mar: Stock hits 52-week low at Rs.708.90 amid market downturn

09 Mar: Technical downgrade to Sell rating confirmed bearish momentum

09 Mar: Valuation shifts to attractive rating despite price weakness

13 Mar: Week closes at Rs.726.75, down 2.24%

Week Open

Rs.743.40

Week Close

Read full news article

Windlas Biotech Ltd is Rated Sell

2026-03-10 10:10:18

Windlas Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Windlas Biotech Ltd Stock Falls to 52-Week Low Amidst Market Downturn

2026-03-09 13:56:49

Windlas Biotech Ltd’s shares declined sharply to a new 52-week low of Rs.708.9 on 9 Mar 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and the broader market over the past year, reflecting subdued financial results and valuation pressures.

Read full news article

Windlas Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-03-09 08:01:59

Windlas Biotech Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests increasing downside pressure amid a challenging market environment for the Pharmaceuticals & Biotechnology sector.

Read full news article

Windlas Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-09 08:00:52

Windlas Biotech Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a downgrade in its overall Mojo Grade to Sell. This change reflects evolving market perceptions amid a challenging pharmaceutical sector landscape, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now presenting a more compelling entry point relative to peers and historical averages.

Read full news article

Windlas Biotech Declines 1.70% Amid Mixed Technical Signals and Sector Headwinds

2026-03-07 12:02:19

Key Events This Week

2 Mar: Stock opens at Rs.754.45 amid broad market decline

4 Mar: Windlas Biotech hits 52-week low of Rs.728.15

5 Mar: Bearish momentum intensifies with technical indicators shifting

6 Mar: Technical momentum shifts to mildly bearish amid mixed signals

Week Open

Rs.756.25

Week Close

Read full news article

Windlas Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-03-06 08:02:52

Windlas Biotech Ltd has experienced a subtle but noteworthy shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid broader market volatility.

Read full news article

View All News